Log in to save to my catalogue

Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective l...

Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective l...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3de49f647a2b4f3eab27ae39c071c722

Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study

About this item

Full title

Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study

Publisher

England: Taylor & Francis

Journal title

Journal of pharmaceutical policy and practice, 2024, Vol.17 (1), p.2372089

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

There is limited evidence to support use of fixed dose combination (FDC) drugs in the treatment of psychiatric disorders. This study aimed to examine the sales and regulatory status of psychotropic FDCs in India, in the context of two government regulatory initiatives.
Official documents were searched to establish an account of the initiatives a...

Alternative Titles

Full title

Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3de49f647a2b4f3eab27ae39c071c722

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3de49f647a2b4f3eab27ae39c071c722

Other Identifiers

ISSN

2052-3211

E-ISSN

2052-3211

DOI

10.1080/20523211.2024.2372089

How to access this item